China National Medicines Corporation Ltd.

SHSE:600511 Stock Report

Market Cap: CN¥26.2b

China National Medicines Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Guotao Tian

Chief executive officer

CN¥1.6m

Total compensation

CEO salary percentagen/a
CEO tenure2yrs
CEO ownershipn/a
Management average tenure2yrs
Board average tenure2.1yrs

Recent management updates

Recent updates

Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

Apr 10
Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal

China National Medicines (SHSE:600511) Could Easily Take On More Debt

Feb 28
China National Medicines (SHSE:600511) Could Easily Take On More Debt

CEO

Guotao Tian (52 yo)

2yrs

Tenure

CN¥1,646,877

Compensation

Mr. Guotao Tian is GM & Director of China National Medicines Corporation Ltd. from April 07, 2022.


Leadership Team

NamePositionTenureCompensationOwnership
Guotao Tian
GM & Director2yrsCN¥1.65mno data
Lichun Luo
Board Secretary2yrsCN¥1.02mno data
Fei Chen
Chief Financial Officerless than a yearno datano data

2.0yrs

Average Tenure

47yo

Average Age

Experienced Management: 600511's management team is considered experienced (2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Guotao Tian
GM & Director2.1yrsCN¥1.65mno data
Xiuchang Jiang
Chairman13.2yrsno datano data
Yong Liu
Director12.4yrsno datano data
Jingyun Liu
Chairman of the Supervisory Board12.4yrsno datano data
Xingxi Yu
Independent Director2.1yrsCN¥133.34kno data
Deyong Wen
Director5yrsno datano data
Xin Jiang
Director2.1yrsCN¥2.21mno data
Xiaojuan Li
Director2.1yrsno datano data
Luwen Shi
Independent Director2.1yrsCN¥133.34kno data
Kai Lu
Supervisor2.1yrsno datano data

2.1yrs

Average Tenure

52yo

Average Age

Experienced Board: 600511's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.